Global Nanoemulsion Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2028
“Global Nanoemulsion Market Analysis Trends, Applications, Analysis, Growth, and Forecast to 2028” is a recent report generated by MarketResearch.biz. The global nanoemulsion market report has been segmented on the basis of drug class, route of administration, distribution channel, and region.
Global Nanoemulsion Market: Overview
Nanoemulsion is also called ultrafine emulsion, miniemulsion, and submicron emulsion. Nanoemulsion are colloidal dispersions that composed of aqueous phase, an oil phase, surfactant and co surfactant at suitable ratios. Nanoemulsion are emulsions with droplet size on the order of 100 nm. Nanoemulsion are formulated using two different methods, the persuasion method and the Brute force method. Some advantages of nanoemulsion over other form of dosage are eliminates variability in absorption, increases the rate of absorption, helps in solubilizing lipophilic drug, increases bioavailability, rapid and efficient penetration of the drug molecule, etc.
Global Nanoemulsion Market: Dynamics
A major factor driving growth of the global nanoemulsion market is increasing awareness regarding chronic diseases. The range of nanoemulsion applications spans diverse fields including drug delivery.
In addition, increasing number of elderly population, changing eating habits, and increasing development of vaccines are some other factors expected to drive the growth of the target market over the next 10 years.
However, products recalls due to presence of some harmful substances and stringent regulations are some of the major factors expected to hamper growth of the target market.
Global Nanoemulsion Market: Trends
Key trend observed in the market currently is that the major companies are collaborating with other local players in order to develop advance medical care product and expand its geographical footprint. In addition, there are several universities especially in the developing countries, which are funding via government for carrying out extensive research capabilities of nanoemulsion for various drug delivery across different disease treatment.
For instance, May 2018, Ascendia Pharmaceuticals LLC, which is a US-based company, collaborated with KC Pharmaceuticals, for the development of 5 OTC ophthalmic drop
Global Nanoemulsion Market: Segmental Analysis
On the basis of route of administration, oral segment is expected to register high growth and is expected to maintain its dominance over the forecast period. This is due to improved physical stability as well as enhance the bioavailability of drugs.
On the basis of distribution channel, retail pharmacies segment is expected to dominate the target market, owing to easiness of accessibility of product and e-commerce segment is expected to register highest CAGR, owing to increasing penetration of smart phone especially in developing countries.
Global Nanoemulsion Market: Regional Analysis
In 2018, the market in North America is estimated to register high market share, owing to increasing government funding for carrying out research and development activates for development of novel product in countries in the region. Asia Pacific market is estimated to register significant growth over the forecoming years. This is primarily due to increasing spending on healthcare sector is a major factors expected to drive growth of the Asia Pacific nanoemulsion market. The markets in Europe is expected to account for moderate revenue share in the global market, followed by Latin America, and Middle East & Africa markets in the global nanoemulsion market.
Global Nanoemulsion Market Segmentation:
Segmentation by drug class:
Segmentation by route of administration:
Segmentation by distribution channel:
- Hospital Pharmacies
- Retail Pharmacies
Segmentation by region:
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Particular Scope Region
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East and Africa
- South Africa
- Rest of Middle East and Africa
Actual Year 2017 Estimated Year 2018 Forecast Period 2018–2027 Revenue in US$
- Allergan plc.
- Ascendia Pharmaceuticals LLC
- Covaris, Inc
- Foamix Pharmaceuticals Ltd.
- Latitude Pharmaceuticals Inc.
- Taiwan Liposome Company, Ltd.
- Santen Pharmaceutical Co., Ltd.
- AstraZeneca Inc.
- Kaken Pharmaceutical Co., Ltd.
- Braun Melsungen AG
Request for TOC
Request for Customization
Don't just take our word. We are trusted by these great companies!